Immune system

Spring Break Review Changes

  • Upcoming review session will be recorded instead of in-person
  • Review material will be posted online for extended access
  • Available by next Monday afternoon before the exam

Introduction to Humoral Immunity

  • Definition: Humoral immunity involves B cells in the immune response.
  • It specifically deals with the production and function of antibodies in response to foreign antigens.

B Cell Activation and Clonal Selection

  • B cells encounter foreign antigens (e.g., bacteria, viruses).
  • They may possess pre-existing receptors that match the antigen.
  • If not, they can modify receptors to match the antigen, akin to molding clay.
  • Clonal production:
    • Singular B cell develops clones after encountering an antigen.
    • Clones are specialized B cells that can bind to the invader.
    • This process takes 2-4 days, indicating that it is not instantaneous.
    • Maximum antibody secretion occurs around day 5-7 post-infection.

Plasma Cells and Antibody Secretion

  • Most clones differentiate into plasma cells.
  • Plasma cells are responsible for antibody secretion.
  • Key Functions of Antibodies:
    • Neutralization: Prevents the pathogen from entering cells.
    • Agglutination: Clumps pathogens for easier removal.
    • Precipitation: Forms insoluble complexes that can be eliminated.
  • Antibodies tag pathogens for destruction by phagocytic cells like neutrophils and macrophages.
  • Involved enhancement of inflammation and recruitment of immune cells to the site of infection.

Case Study: COVID-19

  • COVID-19's spike proteins bind to ACE receptors for cell entry.
  • Antibodies generated (naturally or via vaccines) can block this binding to inhibit viral replication.
  • Importance of specificity in producing antibodies for effective immune response.
Evolution of Pathogens
  • Some antigens (e.g., smallpox, tetanus) remain unchanged for hundreds of years.
  • Others (like the flu) mutate rapidly, necessitating annual vaccinations.
  • Effective binding of antibodies to antigens provides robust protection against reinfection.
  • Clonal selection allows the immune system to develop a tailored response.

Immune Memory

  • Following the initial response, B cells form memory cells that persist in lymph nodes.
  • Upon re-exposure to the same antigen, these cells prompt a faster and stronger response (known as the challenge response).
  • Differences between initial and subsequent exposures:
    • Initial response: Slow antibody production around day 5-10.
    • Secondary response: Faster production in around 2-3 days, often producing significantly more antibodies (5-10 times greater).
  • Example of memory response: Previous flu infections demonstrate greater resistance upon re-exposure.

Types of Immunity

Active Immunity
  • Definition: Immunity that develops due to exposure to an antigen, leading to the formation of memory cells.
  • Types:
    • Naturally acquired active immunity: Occurs after illness (e.g., cold, flu).
    • Artificially acquired active immunity: Achieved through vaccination that stimulates an immune response without causing disease.
Passive Immunity
  • Definition: Immunity gained without the immune system actively producing antibodies.
  • Types:
    • Naturally acquired passive immunity: Antibodies transferred from mother to fetus (via placenta and breast milk).
    • Antibodies (immunoglobulins IgA, IgG) provide immediate, but temporary, protection to infants.
    • Artificially acquired passive immunity: Injection of exogenous antibodies to provide immediate but short-lived protection (e.g., monoclonal antibodies).

Monoclonal Antibodies

  • Definition: Antibodies that are identical and produced from the same immune cell clone.
  • Used in treatments for diseases (e.g., cancer) by targeting specific pathogens or cancer cells.

Vaccination History and Practices

Rollout of Vaccines

  • Key vaccines administered in infancy:
    • DTaP (Diphtheria, Tetanus, Whooping Cough): High success rate (~95%) in the US.
    • MMR (Measles, Mumps, Rubella): Viral vaccine with significant protective impact.
    • Polio vaccine developed by Jonas Salk in the 1930s; underwent shifts from injection to oral forms.
    • Hepatitis B and Chickenpox (Varicella) vaccines introduced for young populations.

Contemporary Vaccine Concerns

  • Resistance to vaccination leads to outbreaks (e.g., Measles resurgence linked to vaccine refusal).
  • Smallpox has been eradicated through successful vaccination efforts.
  • Tuberculosis cases have dramatically decreased globally due to vaccination.

Vaccine Mechanisms

  • Traditional vaccines use inactive or attenuated pathogens to elicit an immune response without causing disease.
  • Examples include using only protein coats of viruses for identification without inducing illness.
  • mRNA vaccines (e.g., COVID-19 vaccines) utilize genetic instruction to prompt cells to produce pathogen proteins, triggering an immune response without using live pathogens.
Ethical Considerations
  • Challenges surrounding vaccine uptake and public health considerations.
  • Need for critical thinking regarding individual health and community immunity levels.